BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 10778976)

  • 1. Clinical significance of serum soluble interleukin 2 receptor-alpha in esophageal squamous cell carcinoma.
    Wang LS; Chow KC; Li WY; Liu CC; Wu YC; Huang MH
    Clin Cancer Res; 2000 Apr; 6(4):1445-51. PubMed ID: 10778976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and up-regulation of interleukin-6 in oesophageal carcinoma cells by n-sodium butyrate.
    Wang LS; Chow KC; Wu CW
    Br J Cancer; 1999 Jul; 80(10):1617-22. PubMed ID: 10408408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between serum levels of soluble interleukin-2 receptor and various disease parameters in patients with squamous cell carcinoma of the esophagus.
    Oka M; Hazama S; Takahashi M; Yamamoto K; Abe T; Yoshino S; Hayashi H; Tangoku A
    Hepatogastroenterology; 1999; 46(28):2254-9. PubMed ID: 10521976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble interleukin-2 receptor and metalloproteinase-9 expression in head and neck cancer: prognostic value and analysis of their relationships.
    El Houda Agueznay N; Badoual C; Hans S; Gey A; Vingert B; Peyrard S; Quintin-Colonna F; Ravel P; Bruneval P; Roncelin S; Lelongt B; Bertoglio J; Fridman WH; Brasnu D; Tartour E
    Clin Exp Immunol; 2007 Oct; 150(1):114-23. PubMed ID: 17680822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between serum levels of interleukin 6, various disease parameters and malnutrition in patients with esophageal squamous cell carcinoma.
    Oka M; Yamamoto K; Takahashi M; Hakozaki M; Abe T; Iizuka N; Hazama S; Hirazawa K; Hayashi H; Tangoku A; Hirose K; Ishihara T; Suzuki T
    Cancer Res; 1996 Jun; 56(12):2776-80. PubMed ID: 8665513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma.
    Sedlaczek P; Frydecka I; Gabryś M; Van Dalen A; Einarsson R; Harłozińska A
    Cancer; 2002 Nov; 95(9):1886-93. PubMed ID: 12404282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis of esophageal squamous cell carcinoma: analysis of clinicopathological and biological factors.
    Wang LS; Chow KC; Chi KH; Liu CC; Li WY; Chiu JH; Huang MH
    Am J Gastroenterol; 1999 Jul; 94(7):1933-40. PubMed ID: 10406262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
    Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J
    J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of nm23-H1 expression in esophageal squamous cell carcinoma.
    Wang LS; Chow KC; Lien YC; Kuo KT; Li WY
    Eur J Cardiothorac Surg; 2004 Aug; 26(2):419-24. PubMed ID: 15296908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
    Naumnik W; Chyczewska E; Kovalchuk O; Tałałaj J; Izycki T; Panek B
    Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases expression correlates with survival in patients with esophageal squamous cell carcinoma.
    Gu ZD; Li JY; Li M; Gu J; Shi XT; Ke Y; Chen KN
    Am J Gastroenterol; 2005 Aug; 100(8):1835-43. PubMed ID: 16086722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
    Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression level of valosin-containing protein (p97) is associated with prognosis of esophageal carcinoma.
    Yamamoto S; Tomita Y; Hoshida Y; Iizuka N; Kidogami S; Miyata H; Takiguchi S; Fujiwara Y; Yasuda T; Yano M; Nakamori S; Sakon M; Monden M; Aozasa K
    Clin Cancer Res; 2004 Aug; 10(16):5558-65. PubMed ID: 15328197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma.
    Takeno S; Noguchi T; Kikuchi R; Uchida Y; Yokoyama S; Müller W
    Cancer; 2002 Jun; 94(11):2874-81. PubMed ID: 12115375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment plasma fibrinogen level correlates with tumor progression and metastasis in patients with squamous cell carcinoma of the esophagus.
    Takeuchi H; Ikeuchi S; Kitagawa Y; Shimada A; Oishi T; Isobe Y; Kubochi K; Kitajima M; Matsumoto S
    J Gastroenterol Hepatol; 2007 Dec; 22(12):2222-7. PubMed ID: 18031385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of astrocyte elevated gene-1 (AEG-1) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis.
    Yu C; Chen K; Zheng H; Guo X; Jia W; Li M; Zeng M; Li J; Song L
    Carcinogenesis; 2009 May; 30(5):894-901. PubMed ID: 19304953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma.
    Hashimoto Y; Ito T; Inoue H; Okumura T; Tanaka E; Tsunoda S; Higashiyama M; Watanabe G; Imamura M; Shimada Y
    Clin Cancer Res; 2005 Apr; 11(7):2597-605. PubMed ID: 15814639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum soluble interleukin-2 receptor, beta2-microglobulin, lactate dehydrogenase and erythrocyte sedimentation rate in children with Hodgkin's lymphoma.
    Bien E; Balcerska A
    Scand J Immunol; 2009 Nov; 70(5):490-500. PubMed ID: 19874554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble interleukin-2 receptor serum level as a predictor of locoregional control and survival for patients with head and neck carcinoma: results of a multivariate prospective study.
    Tartour E; Deneux L; Mosseri V; Jaulerry C; Brunin F; Point D; Validire P; Dubray B; Fridman WH; Rodriguez J
    Cancer; 1997 Apr; 79(7):1401-8. PubMed ID: 9083163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The level of soluble interleukin 2 receptor in esophageal carcinoma patients before and after radiotherapy].
    Liu X; An H; Jiang Y
    Zhonghua Zhong Liu Za Zhi; 1995 Mar; 17(2):97-9. PubMed ID: 7656815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.